Neuroscience trials
Trials closed to recruitment, in follow-up
CCMR Two
The greatest unmet need for people with multiple sclerosis is an effective therapy for the progressive phase. Current treatments suppress the damage caused by the immune system but there is only a limited window in which these can work.…
